Physician
Honeycomb Medical Group PLC
Honeycomb Medical Group PLC was paid $121K by Medicaid between Apr 2023 and Dec 2024, across 105 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 44% of everything it billed.
33Billing provider infoHONEYCOMB MEDICAL GROUP PLC
MEMPHIS, TN 38119
MEMPHIS, TN 38119
33aNPI1548971450assigned 12/12/2022
33bProvider typeInternal Medicine Physician
28Total paid$121K
24GClaims80,596
24DCodes billed105
24AFirst – last monthApr 2023 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Tennessee
Rank by total paid#130 of 581
Median peer was paid$15K
This provider vs. median8.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 52,575 | $38K | |
| 2024incomplete | 28,021 | $84K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 44% | 5,303 | 2,835 | $53K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 16% | 1,375 | 559 | $20K |
| 99497 | 10% | 1,491 | 604 | $13K | |
| 99490 | Ccm add 20min | 5.8% | 3,218 | 2,461 | $7K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 4.3% | 2,605 | 1,168 | $5K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.4% | 1,162 | 470 | $3K |
| 93000 | 1.5% | 1,112 | 417 | $2K | |
| 94010 | 1.4% | 209 | 163 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.3% | 821 | 353 | $2K |
| 36415 | Collection of venous blood by venipuncture | 1.3% | 4,773 | 2,382 | $2K |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | 1.3% | 1,274 | 503 | $2K |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 1.1% | 1,517 | 607 | $1K |
93 more codes
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.0% | 52 | $1K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 1,380 | $1K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 93 | $840.02 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 30 | $753.06 |
| G0445 | High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes | <1% | 361 | $510.14 |
| 99457 | <1% | 796 | $450.18 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 761 | $449.99 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 630 | $428.17 |
| 99458 | <1% | 455 | $401.28 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 297 | $386.55 |
| 80061 | Lipid panel | <1% | 913 | $377.78 |
| 82947 | <1% | 1,168 | $329.55 | |
| 3078F | <1% | 3,173 | $319.41 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 726 | $294.75 |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 127 | $265.41 |
| 99406 | <1% | 463 | $262.26 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 179 | $240.97 |
| 3074F | <1% | 3,065 | $240.35 | |
| 80053 | Comprehensive metabolic panel | <1% | 1,120 | $236.46 |
| 94060 | <1% | 30 | $226.88 | |
| 3079F | <1% | 1,599 | $211.01 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 59 | $179.78 |
| 3075F | <1% | 1,413 | $170.05 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 431 | $118.49 |
| 81003 | <1% | 423 | $111.96 | |
| 3077F | <1% | 406 | $110.00 | |
| 82728 | <1% | 79 | $102.24 | |
| 84439 | <1% | 438 | $97.68 | |
| G2010 | Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment | <1% | 35 | $83.12 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 199 | $80.96 |
| 96160 | <1% | 151 | $47.69 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 455 | $41.85 |
| 82043 | <1% | 296 | $35.64 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 77 | $31.58 |
| 92250 | <1% | 42 | $31.32 | |
| G0443 | Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes | <1% | 48 | $24.68 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 16 | $19.88 |
| 82570 | <1% | 51 | $19.42 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 144 | $17.31 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 430 | $16.12 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 19 | $9.01 |
| 36416 | <1% | 324 | $6.70 | |
| 85027 | <1% | 131 | $6.09 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 32 | $3.15 |
| 96127 | <1% | 62 | $0.77 | |
| V5008 | Hearing screening | <1% | 94 | $0.05 |
| 1170F | <1% | 1,131 | $0.02 | |
| 1126F | <1% | 1,044 | $0.02 | |
| 1003F | <1% | 1,174 | $0.02 | |
| 1160F | <1% | 3,741 | $0.02 | |
| 1158F | <1% | 1,143 | $0.02 | |
| 1159F | <1% | 3,688 | $0.02 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 1,064 | $0.01 |
| 2000F | 0% | 90 | $0.00 | |
| 1000F | 0% | 580 | $0.00 | |
| 3008F | 0% | 3,870 | $0.00 | |
| 4010F | 0% | 935 | $0.00 | |
| 3044F | 0% | 600 | $0.00 | |
| 99454 | 0% | 96 | $0.00 | |
| 3049F | 0% | 451 | $0.00 | |
| 3080F | 0% | 129 | $0.00 | |
| 3048F | 0% | 924 | $0.00 | |
| 94760 | 0% | 21 | $0.00 | |
| 81001 | 0% | 34 | $0.00 | |
| 84436 | 0% | 44 | $0.00 | |
| 2019F | 0% | 57 | $0.00 | |
| 1111F | 0% | 53 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 18 | $0.00 |
| 1036F | 0% | 71 | $0.00 | |
| 3061F | 0% | 32 | $0.00 | |
| 3017F | 0% | 44 | $0.00 | |
| 1125F | 0% | 15 | $0.00 | |
| G9189 | Beta-blocker therapy prescribed or currently being taken | 0% | 52 | $0.00 |
| G8866 | Documentation of patient reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient refusal) | 0% | 26 | $0.00 |
| 4008F | 0% | 145 | $0.00 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 94 | $0.00 |
| G8734 | Elder maltreatment screen documented as negative, follow-up is not required | 0% | 25 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 2,406 | $0.00 |
| 3288F | 0% | 718 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 4,233 | $0.00 |
| 1090F | 0% | 705 | $0.00 | |
| 4013F | 0% | 317 | $0.00 | |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 48 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 203 | $0.00 |
| 99499 | 0% | 510 | $0.00 | |
| 3755F | 0% | 13 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 221 | $0.00 |
| 99080 | 0% | 1,198 | $0.00 | |
| J7610 | Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg | 0% | 22 | $0.00 |
| 1033F | 0% | 377 | $0.00 | |
| G9744 | Patient not eligible due to active diagnosis of hypertension | 0% | 29 | $0.00 |
| 3046F | 0% | 21 | $0.00 | |
| 4040F | 0% | 51 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKATZ, PAUL (M.D./AUTHORIZED OFFICIAL/SOLE OWNER)